Search Results 1331-1340 of 19388 for hemoglobin
Subject has a history of diabetes mellitus type 1, or uncontrolled diabetes mellitus type 2 with hemoglobin A1c (HbA1c) > 9%, or is a diabetic subject with ...
Hemoglobin ≥ 8 g/dL without transfusion or growth factor support within 7 days of the first dose of study drug;; Platelet count ≥ 50 x 10^9/L without ...
Hemoglobin ≥ 7.0 g/dL;; Platelets ≥ 50 x 10^9/L;; Total bilirubin ≤ 1.5 x Upper limit of normal (ULN) (Isolated bilirubin ≥ 1.5 x ULN is acceptable if ...
Absolute neutrophil count ≥ 1,000 cells/mm3 without growth factors (within 14 days of enrollment). Hemoglobin ≥ 8 g/dL (within 14 days of enrollment) ...
A total protein test may be done. Other, more-specific tests, including serum protein electrophoresis (SPEP), can help find the exact source, such as the liver ...
Participation eligibility · Hemoglobin ≥ 9.0 g/dL · Absolute neutrophil count (ANC) ≥ 1500/mm3 · Platelet count ≥ 100,000/mm3 · Total bilirubin ≤ 1.5 x ULN.
- Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable) - No prior invasive (except non-melanoma skin ...
Hemoglobin ≥ 9 g/dL; Total bilirubin ≤ 1.5 institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...
Hemoglobin >8.0 g/dl. Adequate pulmonary function defined as: No or mild dyspnea (≤ Grade 1);; Oxygen saturation measured by pulse oximetry > 90% on room ...
- Hemoglobin ≥ 9.0 g/dL with no blood transfusion in the past 28 days - Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) - Aspartate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.